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INTRODUCTION
Breast conservation surgery (BCS) is a standard procedure 
for patients with breast cancer, and BCS followed by radiation 
provides better cosmetic outcomes with acceptable oncologi-
cal safety than mastectomy [1]. A long marked scar have been 
a issue in some patients with small-sized breasts; thus, endos-
copy-assisted BCS (EABCS) for patients with early breast can-
cer has been introduced mainly from Asian countries includ-
ing Korea and Japan because Asian women tend to have small-
er breasts than those of Western women [2-6]. 
The main advantage of EABCS is an inconspicuous scar, 
because it is performed via a small periareolar and axillary in-
cision for the sentinel lymph node biopsy as an endoscopy port. 
For this reason, endoscopy-assisted breast surgery has been 
successfully established in the field of aesthetic and plastic 
surgery [7-9]. The feasibility and oncological safety of EABCS 
has been shown in short-term results [6,10,11]. Fukuma [3] sug-
gested that the curability of endoscopic breast surgery includ-
ing EABCS is the same as that with conventional methods and 
the local recurrence rate after a total and partial mastectomy. 
However, most studies regarding EABCS are small-sized ret-
rospective cross-sectional studies, and only a few studies are 
case-controlled trials comparing endoscopic surgery with con-
ventional surgery [10,12]. The current study was conducted to 
investigate the feasibility of EABCS in patients with early breast 
cancer by comparing EABCS and conventional BCS in terms 
of operative time, resection margin status, complication rate, 
and relapse-free survival (RFS).
METHODS
Forty-three patients with breast cancer were candidates for 
EABCS at Severance Hospital, Yonsei University Health Sys-
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Purpose: Breast conservation surgery (BCS) has become a stan-
dard treatment method for patients with early breast cancer. En-
doscopy-assisted BCS (EABCS) can be performed through an 
inconspicuous periareolar and a small axillary incision for senti-
nel node biopsy, which may give better cosmetic outcomes than 
conventional BCS skin incisions. This study was designed to eval-
uate the feasibility of EABCS for patients with early breast cancer. 
Methods: Forty-three patients were candidates for EABCS, and 
EABCS was performed in 40 patients with breast cancer between 
January 2008 and July 2010. Their clinicopathological features 
were retrospectively analyzed. Operative time, margin status, 
complications, and relapse-free survival were compared with 
those of patients treated by conventional BCS and who were 
treated at the same institute during the same period. Results: 
The most common lesion site of the EABCS and conventional 
BCS groups was the upper area of the breast. Tumor size in all 
patients was less than 4 cm (range, 0.4–3.7 cm), and nodal involve-
ment was found in eight (20%) patients in the BCS group. The 
mean operative time was 110 minutes for the EABCS group and 
107 minutes for the conventional BCS group, and those were not 
significantly different. No significant difference in frozen or final 
margin status was observed between the EABCS and conven-
tional BCS groups. Relapse-free survival was statistically equiva-
lent between the groups with a median follow-up of 12 months. 
Postoperative complications occurred in five cases in four pa-
tients with EABCS, which was not significantly different from con-
ventional BCS. Conclusion: Performing EABCS in patients with 
early breast cancer seems to be feasible and safe. Further study 
with a longer-term follow-up may be needed to confirm the clini-
cal value of EABCS.
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tem between January 2008 and July 2010. We excluded three 
patients who converted to a mastectomy; one was due to a very 
poor breast shape due to insufficient volume of the remaining 
breast, and two were due to positive resection margins on fro-
zen biopsy. Thus, 40 patients were finally included in the anal-
ysis (Figure 1). All EABCS patients with breast cancer met the 
following criteria at the initial diagnosis: clinical tumor size less 
than 5 cm, clinically node negative, and no evidence of inva-
sion to the skin, pectoralis muscle, or chest wall. All of these 
criteria were evaluated using mammography, ultrasonogra-
phy, and/or magnetic resonance imaging. The patient medical 
records were retrospectively reviewed. A total of 766 patients 
underwent conventional BCS at the same institute during the 
same period, and 85 patients among them were mastectomy 
conversion cases due to positive resection margins on frozen 
pathology specimens. Conventional BCS was performed in 
patients with early breast cancer who had tumors less than 5 
cm, and we excluded patients treated with neoadjuvant che-
motherapy. We finally reviewed the medical data of 681 pa-
tients who underwent conventional BCS. Frozen margin sta-
tus and operative time were recorded in an electric medical 
record (EMR) and were reviewed using the clinical data re-
pository system of the Yonsei University Health System. We 
excluded cooperative cases, such as a thyroidectomy performed 
with BCS at the same time, when calculating the mean total 
operative time. RFS was defined as the time from the date of 
operation to the date of the first event. RFS events were loco-
regional relapse, systemic relapse, and death from any cause. 
Postoperative EABCS complications recorded in the EMR sys-
tem were also reviewed. Tumor stages were determined based 
on the 7th American Joint Committee on Cancer criteria. All 
patients who underwent EABCS or conventional BCS were 
scheduled to receive radiation therapy. Estrogen receptor (ER) 
and progesterone receptor (PR) status of primary breast can-
cer were evaluated from formalin-fixed, paraffin-embedded 
whole sections of surgically resected breast cancer specimens 
using immunohistochemistry (IHC). Primary antibodies for 
ER (clone SP1; NeoMarkers for Lab Vision, Fremont, USA), 
and PR (clone PgR 636; DAKO, Glostrup, Denmark) were 
used for the IHC staining.  
Statistics
Comparisons between continuous variables were analyzed 
with the Student’s t-test. Comparisons between categorical vari-
ables were assessed using the Pearson’s chi-square test or the 
Fisher’s exact test. All tests were two sided. Survival curves were 
plotted and estimated using the Kaplan-Meier method. Inter-
group differences in the survival time were accessed by the log-
rank test. A p-value <0.05 was statistically significant. PASW 
18 (SPSS Inc., Chicago, USA) was used for all statistical analy-
ses.
Surgical technique
The EABCS surgical technique is described briefly as follows 
A B C D E F
Figure 2. Illustrations of the surgical technique. (A) Sentinel lymph node biopsy using technitium-99m was performed in the same manner as a routine 
sentinel lymph node biopsy. (B) The dissection was carried deep over the lateral edge of the pectoralis major muscle, and then the retromammary 
space was identified and dissected using Endosector LE under the view of an endoscopic video system. (C) Sufficient dissection of the retromamma-
ry space of the quadrant to be resected at the beginning of the quadrantectomy is important because it can mobilize the remaining breast parenchy-
ma and provides easy handling of the resection and re-modeling of the remaining tissue. (D) The resection margin was marked using an injection of 
gentian-violet dye along the margin 1 cm distant from the tumor. (E) The lump containing the main lesion was excised using a knife after making a 
periareolar incision and constructing the subcutaneous flaps. Note that surgical clips were applied at the margins to inform the radiation oncologist of 
the exact location of the main lesion. (F) The breast parenchyma and skin wound were approximated.
Analysis
Exclusion:  
85 mastectomy 
conversion
Exclusion:  
3 mastectomy 
conversion
Figure 1. Study enrollment scheme. 
BCS=breast conservation surgery; EABCS=endoscopy-assisted breast 
conservation surgery.
43 candidates  
for EABCS
766 candidates  
for open BCS
Open BCS: 681 patientsEABCS: 40 patients
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(Figure 2). A patient was laid in the supine position in the same 
manner as for the conventional BCS procedure under general 
anesthesia. After sterile surgical draping, a surgeon identified 
the location of the tumor, and a sentinel lymph node biopsy 
was performed via a 3-cm ipsilateral axillary incision. We per-
formed the sentinel lymph node biopsy using technitium-99m 
in the same manner as a routine sentinel lymph node biopsy, 
and did not use endoscopic devices (Figure 2A). The dissected 
sentinel lymph nodes were processed immediately for frozen 
biopsy, and then the surgeon directly identified the lateral bor-
der of the pectoralis muscle using Mezenbaum scissors or a 
conventional Bovie electrocauterizer through the axillary inci-
sion. If the frozen biopsy revealed a metastasis, a conventional 
level I and II axillary lymph node dissection was performed 
via an extended axillary incision. After the dissection had been 
carried deep over the lateral edge of the pectoralis major mus-
cle, the retromammary space was identified and dissected us-
ing an Endosector LE (Curexo, Anyang, Korea), which was 
introduced in a previous study [6], under the view of an endo-
scopic video system (Figures 2B, 3A). The endoscopy was 5- 
mm in diameter, rigid, and oblique at 30°. The retromammary 
space dissection should be performed with caution to avoid 
dissecting the interpectoral space. Sufficiently dissecting the 
retromammary space of the quadrant to be resected at the be-
ginning of the quadrantectomy is important because it mobi-
lizes the remaining breast parenchyma and eases the resection 
and re-modeling of the remaining tissue (Figure 2C). A surgi-
cal gauze pad was placed in the retromammary space to avoid 
iatrogenic injury to the pectoralis major muscle. A 3-4 cm peri-
areolar incision was made after marking the resection margin 
using a gentian-violet dye injection along the margin 1 cm dis-
tant from the tumor (Figure 2D). Subcutaneous flaps were con-
structed using an electrocauterizer with conventional retrac-
tors. We first dissected the closest margin to the nipple-areolar 
complex for the frozen biopsy to exclude cancer invasion into 
this area, and the lump containing the lesion was excised us-
ing a knife (Figure 2E). The gauze placed in the retromamma-
A B
Pectoralis major muscle
Endosector LE
Figure 3. Endoscopic findings of the retromammary space and insertion of surgical clips. (A) Note that the Endosector LE was placed just above the 
pectoralis major muscle and was slid over the retromammary space. (B) Arrow indicates a surgical clip in the remaining breast parenchyma. We usu-
ally inserted the surgical clips in four directions: nipple, inner and/or outer, and upper and/or lower areas of margins.
A
B
Figure 4. Postoperative scars from endoscopic-assisted breast conser-
vation surgery and conventional breast conservation surgery. (A) Post-
operative scar after conventional breast conservation surgery (BCS). (B) 
Postoperative scar after endoscopic-assisted breast conservation sur-
gery (EABCS). Note that the periareolar scar of the patient who under-
went EABCS is more inconspicuous than the incision scar of the patient 
who underwent conventional BCS. 
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breast, and no subareolar or multifocal lesions were observed 
in patients treated with EABCS. No significant difference was 
found in the positive margin status rates of the initial frozen 
biopsy between the EABCS and conventional BCS candidates 
(Table 2).
Margin positive cases were reported in two patients in the 
EABCS group and in 11 patients in the conventional BCS group 
(Table 2). Two patients revealed a positive margin for the per-
manent pathology. Those cases were all negative in frozen sec-
tions during the operation, and focal lobular carcinoma in situ 
and ductal carcinoma in situ margins were revealed in the per-
manent pathology. These cancers were treated by whole breast 
radiation with 9-14 Gy boost radiation therapy on the tumor 
bed. 
The mean total operative time for BCS tended to be slightly 
longer than that of conventional BCS; however, the difference 
was not statistically significant (Table 3). Axillary lymph node 
dissection due to a positive result on the sentinel lymph node 
biopsy prolonged mean total operation time by 37 minutes in 
the EABCS group and by 20 minutes  in the conventional BCS 
group; however, the difference was not statistically significant 
between the two groups.
Postoperative complications occurred in five cases of four 
patients in the EABCS group; two of five cases had prolonged 
seroma with inflammation, one had cellulitis, one developed 
skin wound necrosis, and one had postoperative bleeding (Table 
4). These patients were managed with conservative treatment. 
Table 1. Patients’ characteristics
EABCS
(n=40)
No. (%)
CBCS
(n=681)
No. (%)
p-value
Age (yr)* 51.1±8.4 49.6±9.5 0.31
Tumor location 0.21
   Upper 37 (92.5) 538 (79.0)
   Lower 3 (7.5) 100 (14.7)
   Central/Subareolar 0 39 (5.7)
   Multifocal 0   5 (0.6)
Tumor size (mean±SD)   1.5±0.7   1.5±0.7 0.94
T stage, n=720 0.02
   Tis 1 (2.5) 131 (19.3)
   T1 30 (75.0) 442 (65.0)
   T2   9 (22.5) 107 (15.7)
Nodal status, n=712 0.68
   Negative 32 (80.0) 519 (77.2)
   Positive   8 (20.0) 153 (22.8)
ER, n=710 0.28
   Negative 13 (32.5) 167 (24.9)
   Positive 27 (67.5) 503 (75.1)
PR, n=710 0.99
   Negative 14 (35.0) 253 (34.9)
   Positive 26 (65.0) 436 (65.1)
Chemotherapy, n=718 0.11
   None 16 (40.0) 359 (52.2)
   Done 24 (60.0) 319 (47.8)
Endocrine therapy, n=695 0.44
   None   9 (25.7) 210 (31.8)
   Done 26 (74.3) 450 (68.2)
EABCS=endoscopy-assisted breast conservation surgery; CBCS=conven-
tional breast conservation surgery; SD=standard deviation.
*Mean±SD.
Table 2. Frozen and permanent margin status between EABCS and 
conventional BCS
EABCS  
candidates 
(n=42)
No. (%)
CBCS  
candidates 
(n=766)
No. (%)
p-value
Frozen margin status
   Negative 40 (95.2) 681 (88.9) 0.30
   Positive 2 (4.8)   85 (11.1)
Permanent margin status, n=721 0.20
   Negative 38 (95.0) 670 (98.4)
   Positive 2 (5.0) 11 (1.6)
EABCS=endoscopy-assisted breast conservation surgery; CBCS=con ven-
tional breast conservation surgery.
Table 3. Operation time between EABCS and conventional BCS
EABCS  
(mean±SD)
CBCS  
(mean±SD)
p-value
Overall   110.0±28.7 107.32±33.5 0.62
SLNB group   102.1±22.9 102.38±28.8 0.96
ALND group 139.50±30.3 122.49±40.5 0.24
EABCS=endoscopy-assisted breast conservation surgery; CBCS=con ven-
tional breast conservation surgery; SD=standard deviation; SLNB=sentinel 
lymph node biopsy; ALND=axillary lymph node dissection.
ry space was removed, and the cavity margins were resected 
and processed for a frozen biopsy. Surgical clips were inserted 
to inform radiation oncologists of the exact location of the 
main lesion (Figure 3B). We inserted a suction drain if neces-
sary, and the adjacent breast parenchyma was mobilized and 
approximated with minimal distortion to the remaining breast. 
We sealed the wound with two layers of gauze after skin clo-
sure (Figure 2F). All specimens obtained from the operation 
were processed for routine pathology. The postoperative im-
ages of the patients treated with EABCS and conventional BCS 
are shown in Figure 4.
RESULTS
The median age of patients treated with EABCS was 51 years 
(range, 28-68 years), and all patients were female. No differ-
ences in the clinicopathological characteristics were observed, 
except T-stage; and mean tumor size was not different between 
the two groups (Table 1). Most lesions in the EABCS group 
were located in the upper medial or lateral quadrant of the 
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The difference in the complication rates between the EABCS 
and conventional BCS groups was not statistically significant.
No recurrences were reported in the EABCS group and two 
recurrences occurred in the conventional BCS group with a 
median follow-up of 12 months (Figure 5). No significant dif-
ference in RFS was observed between the two groups.
DISCUSSION
The advantage of EABCS is an inconspicuous scar, which 
may increase a patient’s satisfaction [5,6,10]. In addition, early 
dissection of the retromammary space with endoscopic devices 
before forming the subcutaneous flap may help with the han-
dling of the breast tissue to be resected and make remodeling 
of the remaining breast tissues easier. In contrast, the addition-
al cost for endoscopic devices and the learning period to de-
velop the EABCS technique are a disadvantage of EABCS. Al-
though the Japanese health authority agreed to reimburse the 
cost for endoscopic breast surgery, no definite reimbursement 
consensus was reached for endoscopic breast surgery in Europe 
and North America [11]. Compared with previous techniques 
performed with various endoscopic devices, retractors, or en-
hanced coagulating and cutting devices such as the harmonic 
scalpel [5,6,13], our technique can be performed with only one 
set of endoscopic devices including an Endosector LE and an 
endoscopic video system for dissecting the retromammary 
space. Therefore, the cost for using the additional devices might 
be reduced. Furthermore, inserting surgical clips into the space 
may help inform the radiation oncologists about the exact re-
section area for appropriate radiation therapy. 
The feasibility of EABCS was analyzed in terms of operative 
time, resection margin status, and RFS. Operative time is usu-
ally affected by the number of cumulative cases or operation 
type [5,10], and it has been reported that EABCS takes longer 
than conventional BCS [6]. However, although we included 
EABCS cases during the earlier period, which usually took lon-
ger than those after the learning period, to calculate the mean 
operative time, the difference in the mean operative time be-
tween EABCS and conventional BCS was only about 10 min-
utes, and it was not significant. This finding was correlated 
with that of a previous study [10]. 
Resection margin status is a risk factor for local recurrence 
in patients with early breast cancer [14,15], and it may be a cru-
cial factor for accessing EABCS feasibility. The resection mar-
gin positive rate for EABCS is 0-5% [5,6,10], compared with 
about a 10% margin positive rate for conventional BCS [1,16]. 
A direct comparison of the differences in the positive margin 
rates between EABCS and conventional BCS is difficult due to 
heterogeneous study designs, including the definition of a pos-
itive margin, surgeon experience, and extent of surgery. The 
current study demonstrated no significant difference in resec-
tion margin status, including frozen and permanent patholog-
ical results, between EABCS and conventional BCS, although 
all procedures were performed at a single institution and in-
cluded patients treated by EABCS during the early learning 
period.
Only a few studies have reported recurrence or survival data 
for EABCS. Previous studies indicated that patients with EABCS 
have no local or distant recurrence with a mean follow-up pe-
riod of 24-25 months, and the retrospective data of 966 pa-
tients with EABCS from a single institute in Japan reported a 
0.62% local recurrence rate [6,10,11]. These results correspond 
with our data. However, those studies, including our study, 
were retrospective trials, and the follow-up periods were short. 
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Figure 5. Relapse-free survival (RFS) between endoscopic-assisted 
breast conservation surgery (EABCS) and conventional breast conser-
vation surgery (BCS).
Table 4. Complications between EABCS and conventional BCS
EABCS  
(n=40)
No. (%)
CBCS  
(n=681)
No. (%)
p-value
None 36 (90.0) 646 (94.9) 0.25
Present 4 (10.0) 33 (4.8)
Complications 1.0
   Prolonged seroma with inflammation 2 (5) 7 (1.0)
   Cellulitis* 1 (2.5) 6 (0.8)
   Fat necrosis 0 3 (0.4)
   Bleeding or hematoma 1 (2.5) 8 (1.1)
   Suture granuloma 0 1 (0.1)
   Skin wound necrosis 1 (2.5) 8 (1.1)
EABCS=endoscopy-assisted breast conservation surgery; CBCS=con ven-
tional breast conservation surgery.
*Five of seven cellulitis cases, one case of the EABCS group and four cases 
of the CBCS group, occurred during adjuvant chemotherapy.
Endoscopy-Assisted Breast Conservation Surgery 57
DOI: 10.4048/jbc.2011.14.1.52 http://ejbc.kr
Further randomized controlled trials with a longer-term fol-
low-up should be conducted to support this technique. 
The EABCS complications seemed to be acceptable. Hem-
orrhage, hematoma, skin burns, and wound infections are com-
mon complications of EABCS in the literature, and those com-
plications are treatable and the possibility of re-operation due 
to the complications is low [6,10]. Our study showed similar 
results to previous studies, and we also demonstrated that the 
complication rates in the EABCS group were not significantly 
different from those in the conventional BCS group.
Complete mastery of EABCS requires eye-hand coordina-
tion, a basic understanding of endoscopic instruments, and 
adequate patient selection. This may be the key to success of 
endoscopic breast surgery, and learning from other endoscop-
ic surgery may help to enhance EABCS skill [11].
Nonetheless, there are some limitations to our study. This 
study was a retrospective trial with a small volume of enrolled 
patients and a short follow-up period; therefore, further prospec-
tive trials with a longer-term follow-up will be necessary to con-
firm the clinical role of EABCS. However, to our knowledge, 
this is the only study that has compared EABCS with conven-
tional BCS in terms of various clinicopathological features such 
as operative time, complication rates, margin status, and RFS.
In conclusion, the results show that operative time, compli-
cations, resection margin status, and RFS of EABCS in patients 
with early breast cancer were not significantly different from 
those of conventional BCS. The complication rate of EABCS 
was not serious and the complications were treatable. Some 
novel EABCS approaches including the minimal use of endo-
scopic devices and inserting a surgical clip have been intro-
duced. Thus, although the oncological safety has not yet been 
confirmed, this study indicated that EABCS for patients with 
early breast cancer is feasible and safe. Taken together, EABCS 
may play a role in better cosmetic scar management for pa-
tients with early breast cancer.
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